VANCOUVER, BC / ACCESSWIRE / March 30, 2017 / Jaxon Minerals Inc. (TSX-V: JAX) (FSE: 0U3) (“Jaxon” or the “Company”) is pleased to announce that it has increased its proposed financing (see news release dated March 27, 2017) from a maximum of 7 million units, to a maximum of 8 million units, for total gross proceeds of $560,000. A finder’s fee commensurate with TSX Venture Exchange policies will be paid where applicable.

ON BELHALF OF THE BOARD OF DIRECTORS
JAXON MINERALS INC.

“Jason Cubitt”
Jason Cubitt, President

For further information regarding Jaxon Minerals Inc., please contact Jason Cubitt at 604-608-0400, Toll free: 1-877-608-0007.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Jaxon Minerals Inc.

ReleaseID: 458599

CALGARY, ALBERTA / ACCESSWIRE / March 30, 2017 / Jay Richardson, Chief Executive Officer and Chairman of EnerSpar Corp. (formally Walmer Capital Corp. (TSX-V: WAL.H)) (TSX-V: ENER) (the “Company” or “EnerSpar”), is pleased to announce that EnerSpar Corp. has closed its Qualifying Transaction. The Company previously announced on November 3, 2016 the purchase agreement with Globex Mining Enterprises Inc. (TSX: GMX) (OTCQX: GLBXF) (FSE: G1MN) (“Globex”) whereby the Company will acquire the 100% legal and beneficial interest in the mineral property referred to as the Johan Beetz Feldspar Property, located in Johan Beetz/Iles et ilets de Mingan 03 Township, Province of Quebec (the “Property”).

The Qualifying Transaction

Pursuant to the terms of the Qualifying Transaction, the Company issued a total of 2,000,000 shares to Globex. Further details regarding the Qualifying Transaction can be found in the Company’s Filing Statement (the “Filing Statement”) dated March 22, 2017, filed under the Company’s profile on SEDAR, and in the prior press releases of the Company. The Exchange has provided conditional acceptance of the Qualifying Transaction including the listing of the Company as a Tier 2 Mining Issuer on the Exchange. The parties to the Qualifying Transaction will be making their final submission to the Exchange post-closing in connection with the Exchange’s issuance of its listing bulletin.

Subscription Receipt Financing

As previously announced, the Company completed a subscription receipt financing for $512,500.00 in gross proceeds. In connection with the completion of the Qualifying Transaction, the subscription receipts converted on a one-for-one basis into a total of 10,250,000 units of the Company, with each unit comprised of one common share of the Company and one half of one common share purchase warrant, each whole warrant being exercisable into a full common share for a period of 18 months from the closing date of the offering at a price of $0.10 per share. Escrowed proceeds of the offering have been released from escrow to the Company.

Name and Ticker Change

Prior to completing the Qualifying Transaction, the Company changed its name from Walmer Capital Corp. to EnerSpar Corp. The Company expects that the shares will commence trading on the TSX Venture Exchange under the new name and ticker symbol “ENER” upon the opening of the markets on April 3, 2017.

Finder’s Fee

In connection with the completion of the Qualifying Transaction, the Company issued 400,000 common shares to an arm’s length party as payment of a finder’s fee.

Escrow

James Richardson, Peter Andrews, Peter Bloch, and John Arnold, as Principals (as defined under Exchange Policy) of the Company, have entered into a Tier 2 Value Escrow Agreement with the Exchange, and Computershare Investor Services Inc., as escrow agent, in respect of an aggregate of 1,810,000 shares. Under the terms of escrow, 10% of such escrowed shares are immediately released upon closing with subsequent 15% releases occurring 6, 12, 18, 24, 30, and 36 months from closing.

ON BEHALF OF THE BOARD OF DIRECTORS:

Jay Richardson, Chief Executive Officer and Director
Contact: jay.richardson@sympatico.ca
Toronto Office: 416-410-JAYR [5297]

READER ADVISORY

Neither the TSX Venture Exchange Inc. (“TSX-V”) nor its Regulation Services Provider (as that term is defined in the policies of the TSX-V) has in any way passed upon the merits of the transactions described herein and neither of the foregoing entities has in any way approved or disapproved of the contents of this press release.

This press release may contain certain forward-looking information and statements (“forward-looking information”) within the meaning of applicable Canadian securities legislation, that are not based on historical fact, including without limitation statements containing the words “believes,” “anticipates,” “plans,” “intends,” “will,” “should,” “expects,” “continue,” “estimate,” “forecasts,” and other similar expressions. Readers are cautioned to not place undue reliance on forward-looking information. Actual results and developments may differ materially from those contemplated by these statements. The Company undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of the Company, its securities, or financial or operating results (as applicable). Although the Company believes that the expectations reflected in forward-looking information in this press release are reasonable, such forward-looking information has been based on expectations, factors and assumptions concerning future events which may prove to be inaccurate and are subject to numerous risks and uncertainties, certain of which are beyond the Company’s control, including the risk factors discussed in the Filing Statement which are incorporated herein by reference and are available through SEDAR at www.sedar.com. The forward-looking information contained in this press release is expressly qualified by this cautionary statement and is made as of the date hereof. The Company disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.

SOURCE: EnerSpar Corp.

ReleaseID: 458596

SUNRISE, FL / ACCESSWIRE / March 30, 2017 / U.S. Stem Cell, Inc. (USCC) (OTCQB: USRM), a Florida corporation and leader in novel regenerative medicine solutions and physician-based stem cell therapies for human and animal patients, has applied for Regenerative Advanced Therapy (RAT) designation from the FDA.

Following the passing of the 21st Century Cures Act, U.S. Stem Cell, Inc. has applied to the FDA for RAT Designation. We have recently heard from the FDA, who has requested additional information regarding the MARVEL Phase II/III trial. We have provided all requested information to the FDA and are hopeful that the FDA will continue their expeditious review of our MyoCell product. Thanks to the REGROW component of the Cures Act, the FDA will grant RAT designation for a regenerative medicine therapy that is intended to treat, modify, reverse, or cure a serious or life-threatening disease and demonstrates preliminary clinical evidence that the product has the potential to address unmet medical needs for a disease. We believe that our MyoCell product meets these requirements, as we have demonstrated clinical efficacy in both preclinical and clinical studies, including our most recent MARVEL trial publication (review full publication here: https://www.ncbi.nlm.nih.gov/pubmed/21982657). If RAT designation is granted, this could expedite the approval process with the FDA.

More information on the FDA’s new RAT Designation can be found here: https://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ucm537670.htm.

About U.S. Stem Cell, Inc.

US Stem Cell, Inc. (formerly Bioheart, Inc.) is an emerging enterprise in the regenerative medicine / cellular therapy industry. We are focused on the discovery, development, and commercialization of cell based therapeutics that prevent, treat, or cure disease by repairing and replacing damaged or aged tissue, cells, and organs and restoring their normal function. We believe that regenerative medicine / cellular therapeutics will play a large role in positively changing the natural history of diseases, ultimately, we contend, lessening patient burdens, as well as reducing the associated economic impact disease imposes upon modern society.

Our business, which includes three operating divisions (US Stem Cell Training, Vetbiologics, and US Stem Cell Clinic), includes the development of proprietary cell therapy products, as well as revenue generating physician and patient based regenerative medicine / cell therapy training services, cell collection and cell storage services, the sale of cell collection and treatment kits for humans and animals, and the operation of a cell therapy clinic. Management maintains that revenues and their associated cash in-flows generated from our businesses will, over time, provide funds to support our clinical development activities as they do today for our general business operations. We believe the combination of our own therapeutics pipeline combined with our revenue generating capabilities provides the Company with a unique opportunity for growth and a pathway to profitability.

Forward-Looking Statements:

Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may,” “will,” “to,” “plan,” “expect,” “believe,” “anticipate,” “intend,” “could,” “would,” “estimate,” or “continue,” or the negative other variations thereof, or comparable terminology, are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Except as required by law, we assume no obligation to update these forward-looking statements publicly, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

The Company is subject to the risks and uncertainties described in its filings with the Securities and Exchange Commission, including the section entitled “Risk Factors” in its Annual Report on Form 10-K for the year ended December 31, 2016, and its Quarterly Reports on Form 10-Q.

Media Contact:

U.S. Stem Cell, Inc.
13794 NW 4th Street, Suite 212
Sunrise, Fl 33325
Phone: 954.835.1500
Email: usstemcell@us-stemcell.com

SOURCE: U.S. Stem Cell, Inc.

ReleaseID: 458595

IRVINE, CA / ACCESSWIRE / March 30, 2017 / Khang & Khang LLP (the “Firm”) announces a class action lawsuit against Patriot National, Inc. (“Patriot” or the “Company”) (NYSE: PN). Investors who purchased or otherwise acquired shares between August 15, 2016 and March 3, 2017, inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the May 15, 2017 lead plaintiff motion deadline.

If you purchased shares of Patriot during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

There has been no class certification in this case. Until certification occurs, you are not represented by an attorney. You may choose to take no action and remain a passive class member.

The complaint alleges that during the Class Period, Patriot made materially false and misleading statements and/or failed to disclose that: the Company’s special committee was beholden to CEO Steve Mariano, therefore, the special committee was operating for the benefit of Mariano and not Patriot National or its shareholders; that the special committee did not independently assess the merits of the Ebix transaction; that the special committee was not exploring strategic alternatives in order to maximize shareholder value; and that as a result of the above, Patriot’s statements about its business, operations, and prospects were false and misleading and/or lacked a reasonable basis. When this news was released to the public, shares of Patriot fell in value, thus causing investors harm.

If you wish to learn more about this lawsuit, or if you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at joon@khanglaw.com.

This press release may constitute Attorney Advertising in some jurisdictions.

Contacts

Joon M. Khang, Esq.
Telephone: 949-419-3834
Facsimile: 949-225-4474
joon@khanglaw.com

SOURCE: Khang & Khang LLP

ReleaseID: 458594

D. Jennifer Rhee to be Appointed CFO

MONTREAL, QC / ACCESSWIRE / March 30, 2017 / Loop Industries, Inc. (OTCQB: LLPP), an environmentally responsible manufacturer of Purified Terephthalic Acid (PTA) and Mono Ethylene Glycol (MEG), today announced that D. Jennifer Rhee will become its new Chief Financial Officer, replacing Cesar Contla, who will be staying on in his new role as corporate controller. Ms. Rhee will assume the role in early April 2017.

“We are excited to announce Jennifer joining Loop as CFO,” said Chief Executive Officer, Daniel Solomita. “Jennifer brings extensive financial experience and will be instrumental in helping us grow. In addition to outstanding analytical skills, she will also provide key leadership in the execution of Loop’s strategic and financial plans.”

Ms. Rhee has over 25 years of finance, accounting, international tax and management experience. She has been a partner with Richter LLP, a financial advisory services firm, since January 2007, and has previously worked at Richter LLP in other capacities since 2003. Ms. Rhee has practiced in the areas of international taxation and transfer pricing and was responsible for creating and building the firm’s transfer pricing practice. She has also assumed leadership roles within the firm, including the expansion of the firm’s presence in the Toronto market, chair of the firm’s marketing committee, a member of the firm’s nominating committee as well as a member of the firm’s board of directors. Ms. Rhee received her Bachelor of Commerce from McGill University and is a CPA, CA with the Canadian Order of Chartered Professional Accountants.

About Loop Industries, Inc.

Loop Industries is an environmentally responsible manufacturer of Purified Terephthalic Acid (PTA) and Mono Ethylene Glycol (MEG), the fundamental chemical components used in manufacturing polyethylene terephthalate (PET). PET plastic is most commonly found in beverage bottles, consumer packaging and polyester fiber. Loop Industries’ proprietary process sustainably converts waste plastics into high purity PTA and MEG that can be used to create up to 100 percent recycled food-grade PET resin. This commercial-grade PET resin can be used in a variety of bottling, consumer packaging and other industrial applications.

Forward-Looking Statements

This news release contains “forward-looking statements.” Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond Loop’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) commercialization of our technology, (ii) development and protection of our intellectual property, (iii) industry competition, (iv) our ability to raise capital to expand our operations, (v) product demand, market and customer acceptance of our products, (vi) our ability to conduct operations if there are changes in laws, regulations or government policies related to our business, and (vii) general industry and market conditions and growth rates and general economic conditions. More detailed information about Loop industries and the risk factors that may affect the realization of forward looking statements is set forth in our filings with the Securities and Exchange Commission (SEC). Investors and security holders are urged to read these documents free of charge on the SEC’s web site at http://www.sec.gov. Loop Industries assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Contact:

Company Contact
Susan Khouloujian
T: 450.951.8555
E: IR@loopindustries.com

SOURCE: Loop Industries, Inc.

ReleaseID: 458593

VANCOUVER, BC / ACCESSWIRE / March 30, 2017 / Canadian Zeolite Corp. (the “Company”) (TSX-V: CNZ) (OTCQB: CNZCF) (FSE: ZEON) is pleased to announce the launching of a new product line for the animal feed and poultry production industries. In addition to the previously announced Z-Lite 2% animal feed additive, the Company is now rolling out a line of natural zeolite animal bedding products – Poultry Sense, Zeolite/Citric Acid Blend, Activated Poultry Sense, and Activated Barn Sense. These products benefit animal hygiene, provide cleaner dryer bedding, and the reduction of ammonia and odour. All of these new products are now available for distribution.

Canadian Zeolite reports that initial results at the commercial operation at Pillar Poultry in Ontario are positive with regards to ammonia reduction. The operations have recorded up to a 70% reduction in the barns that have implemented “natural zeolite” alone. These results validate the effectiveness of our natural zeolite for these massive markets. This represents another opportunity for Canadian Zeolite to commercialize its products for the North American marketplace in the animal and poultry production industries.

CEO, Ray Paquette, states, “These market ready new products are a huge step forward for Canadian Zeolite in meeting the demands of the animal feed and bedding industries. The positive results from our end-users offers the Company an opportunity to become a significant supplier to the animal and poultry production industries.”

Canadian Zeolite continues to move forward with the development of “green-tech” products for composting, water filtration, and growing mediums to meet the ever increasing demands of these markets.

On behalf of the Board of Directors
“Ray Paquette”
President & CEO
604.684.3301
www.canadianzeolite.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Some statements in this news release contain forward-looking information. These statements include, but are not limited to, statements with respect to future expenditures. These statements address future events and conditions and, as such, involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the statements. Such factors include, among others, the ability to complete contemplated work programs and the timing and amount of expenditures. Canadian Zeolite does not assume the obligation to update any forward-looking statement.

SOURCE: Canadian Zeolite Corp.

ReleaseID: 458591